Brivaracetam – July 2026

  • Brand names:
    • Briviact®
  • Pharmaceutical Company:
    • UCB AUSTRALIA PROPRIETARY LIMITED
  • Condition/Indication: Intractable focal onset seizures
  • Meeting Date: July 2026
Public Summary Documents
Last updated
13 November 2026